Alzheimer's Disease Vaccine 2010 ~Alzheimer's Disease Research Papers 2010 on Vaccine
Fouquet C, Tobin C, Rondi-Reig L. A new approach for modeling episodic memory from rodents to humans: the temporal order memory. Behav Brain Res. 2010 Dec 31;215(2):172-9. Alzheimer’s Disease Vaccine 2010
Komatsu H, Feingold-Link E, Sharp KA, Rastogi T, Axelsen PH. Intrinsic Linear Heterogeneity of Amyloid {beta} Protein Fibrils Revealed by Higher Resolution Mass-per-length Determinations. J Biol Chem. 2010 Dec 31;285(53):41843-51. Alzheimer’s Disease Vaccine 2010
Choi JH, Choi AY, Yoon H, Choe W, Yoon KS, Ha J, Yeo EJ, Kang I. Baicalein protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis through inhibition of reactive oxygen species production and CHOP induction. Exp Mol Med. 2010 Dec 31;42(12):811-22. Alzheimer’s Disease Vaccine 2010
Wirths O, Erck C, Martens H, Harmeier A, Geumann C, Jawhar S, Kumar S, Multhaup G, Walter J, Ingelsson M, Degerman-Gunnarsson M, Kalimo H, Huitinga I, Lannfelt L, Bayer TA. Identification of Low Molecular Weight Pyroglutamate A{beta} Oligomers in Alzheimer Disease: A NOVEL TOOL FOR THERAPY AND DIAGNOSIS. J Biol Chem. 2010 Dec 31;285(53):41517-24. Alzheimer’s Disease Vaccine 2010
Sarell CJ, Wilkinson SR, Viles JH. Substoichiometric Levels of Cu2+ Ions Accelerate the Kinetics of Fiber Formation and Promote Cell Toxicity of Amyloid-{beta} from Alzheimer Disease. J Biol Chem. 2010 Dec 31;285(53):41533-40. Alzheimer’s Disease Vaccine 2010
Cheng S, Li L, He S, Liu J, Sun Y, He M, Grasing K, Premont RT, Suo WZ. GRK5 Deficiency Accelerates {beta}-Amyloid Accumulation in Tg2576 Mice via Impaired Cholinergic Activity. J Biol Chem. 2010 Dec 31;285(53):41541-8. Alzheimer’s Disease Vaccine 2010
Popkie AP, Zeidner LC, Albrecht AM, D'Ippolito A, Eckardt S, Newsom DE, Groden J, Doble BW, Aronow B, McLaughlin KJ, White P, Phiel CJ. Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci. J Biol Chem. 2010 Dec 31;285(53):41337-47. Alzheimer’s Disease Vaccine 2010
Sant'anna MC, de Matas Soares V, Seibt KJ, Ghisleni G, Rico EP, Rosemberg DB, de Oliveira JR, Schröder N, Bonan CD, Bogo MR. Iron exposure modifies acetylcholinesterase activity in zebrafish (Danio rerio) tissues: distinct susceptibility of tissues to iron overload. Fish Physiol Biochem. 2010 Dec 31; Alzheimer’s Disease Vaccine 2010
Bekris LM, Galloway NM, Millard S, Lockhart D, Li G, Galasko DR, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Leverenz JB, Seubert P, Tsuang DW, Peskind ER, Yu CE. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiol Aging. 2010 Dec 31; Alzheimer’s Disease Vaccine 2010
Lin MS, Hung KS, Chiu WT, Sun YY, Tsai SH, Lin JW, Lee YH. Curcumin enhances neuronal survival in N-methyl-D-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 31; Alzheimer’s Disease Vaccine 2010
Ksiezak-Reding H, Ho L, Santa-Maria I, Diaz-Ruiz C, Wang J, Pasinetti GM. Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols. Neurobiol Aging. 2010 Dec 31; Alzheimer’s Disease Vaccine 2010
Filipcik P, Zilka N, Bugos O, Kucerak J, Koson P, Novak P, Novak M. First transgenic rat model developing progressive cortical neurofibrillary tangles. Neurobiol Aging. 2010 Dec 31; Alzheimer’s Disease Vaccine 2010
Ittner LM, Götz J. Amyloid-ß and tau - a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci. 2010 Dec 31; Alzheimer’s Disease Vaccine 2010
Lane RF, Small SA, Gatson JW, Ehrlich ME, Gandy S. Protein kinase C and rho activated coiled coil protein kinase 2 (ROCK2) modulate Alzheimer's APP metabolism and phosphorylation of the Vps10-domain protein, SorL1. Mol Neurodegener. 2010 Dec 30;5(1):62. Alzheimer’s Disease Vaccine 2010
Rosario BL, Weissfeld LA, Laymon CM, Mathis CA, Klunk WE, Berginc MD, James JA, Hoge JA, Price JC. Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET. Neuroimage. 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Leung KK, Barnes J, Modat M, Ridgway GR, Bartlett JW, Fox NC, Ourselin S, the Alzheimer’s Disease Neuroimaging Initiative. Brain MAPS: An automated, accurate and robust brain extraction technique using a template library. Neuroimage. 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Bishop CA, Jenkinson M, Declerck J, Merhof D. Novel Fast Marching for Automated Segmentation of the Hippocampus (FMASH): Method and Validation on Clinical Data. Neuroimage. 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Vemuri P, Simon G, Kantarci K, Whitwell JL, Senjem ML, Przybelski SA, Gunter JL, Josephs KA, Knopman DS, Boeve BF, Ferman TJ, Dickson DW, Parisi JE, Petersen RC, Jack CR. Antemortem Differential Diagnosis of Dementia Pathology using Structural MRI: Differential-STAND. Neuroimage. 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Harrington AJ, Knight AL, Caldwell GA, Caldwell KA. C. elegans as a model system for identifying effectors of a-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease. Methods. 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Marqué A, Hommet C, Constans T, Perrier D, Bardet F, Chaput M, Mondon K. [Building and validation of a test evaluating verbal recognition memory: The Forty test (f40).] Rev Neurol (Paris). 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Kota P, Dokholyan NV. Approaches for probing the sequence space of substrates recognized by molecular chaperones. Methods. 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Lampron A, Gosselin D, Rivest S. Targeting the hematopoietic system for the treatment of Alzheimer's disease. Brain Behav Immun. 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Mizoguchi K, Shoji H, Tanaka Y, Tabira T. Ameliorative effect of traditional Japanese medicine yokukansan on age-related impairments of working memory and reversal learning in rats. Neuroscience. 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Chang Z, Luo Y, Zhang Y, Wei G. Interactions of Aß25-35 ß-Barrel-like Oligomers with Anionic Lipid Bilayer and Resulting Membrane Leakage: An All-Atom Molecular Dynamics Study. J Phys Chem B. 2010 Dec 30; Alzheimer’s Disease Vaccine 2010
Kishimoto Y, Terada S, Sato S, Yoshida H, Honda H, Takeda N, Oshima E, Ishihara T, Kuroda S. Repetitive questioning behavior in Alzheimer's disease: Relationship to regional cerebral blood flow. Psychiatry Res. 2010 Dec 30;184(3):151-6. Alzheimer’s Disease Vaccine 2010
Klein RC, Mace BE, Moore SD, Sullivan PM. Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2. Neuroscience. 2010 Dec 29;171(4):1265-72. Alzheimer’s Disease Vaccine 2010
Sarasa L, Gallego C, Monleón I, Olvera A, Canudas J, Montañés M, Pesini P, Sarasa M. Cloning, sequencing and expression in the dog of the main amyloid precursor protein isoforms and some of the enzymes related with their processing. Neuroscience. 2010 Dec 29;171(4):1091-101. Alzheimer’s Disease Vaccine 2010
Liu G, Prabhakar A, Aucoin D, Simon M, Sparks S, Robbins KJ, Sheen A, Petty SA, Lazo ND. Mechanistic studies of peptide self-assembly: transient a-helices to stable ß-sheets. J Am Chem Soc. 2010 Dec 29;132(51):18223-32. Alzheimer’s Disease Vaccine 2010
Basi GS, Hemphill S, Brigham EF, Liao A, Aubele DL, Baker J, Barbour R, Bova M, Chen XH, Dappen MS, Eichenbaum T, Goldbach E, Hawkinson J, Lawler Herbold R, Hu K, Hui T, Jagodzinski JJ, Keim PS, Kholodenko D, Latimer LH, Lee M, Marugg J, Mattson MN, McCauley S, Miller JL, Motter R, Mutter L, Neitzel ML, Ni H, Nguyen L, Quinn K, Ruslim L, Semko CM, Shapiro P, Smith J, Soriano F, Szoke B, Tanaka K, Tang P, Tucker JA, Ye XM, Yu M, Wu J, Zu YZ, Garofalo AW, Sauer JM, Konradi AW, Ness D, Shopp G, Pleiss MA, Freedman SB, Schenk D. Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease. Alzheimers Res Ther. 2010 Dec 29;2(6):36. Alzheimer’s Disease Vaccine 2010
Kim DY, Gersbacher MT, Inquimbert P, Kovacs DM. Reduced sodium channel Nav1.1 levels in BACE1-null mice. J Biol Chem. 2010 Dec 29; Alzheimer’s Disease Vaccine 2010
Crish SD, Calkins DJ. Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms. Neuroscience. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Vidal R, Caballero B, Couve A, Hetz C. Converging Pathways in the Occurrence of Endoplasmic Reticulum (ER) Stress in Huntington's Disease. Curr Mol Med. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Gill DP, Koepsell TD, Hubbard RA, Kukull WA. Risk of Decline in Functional Activities in Dementia With Lewy Bodies and Alzheimer Disease. Alzheimer Dis Assoc Disord. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Kessels RP, Remmerswaal M, Wilson BA. Assessment of Nondeclarative Learning in Severe Alzheimer Dementia: The Implicit Memory Test (IMT). Alzheimer Dis Assoc Disord. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Sabbagh MN, Agro A, Bell J, Aisen PS, Schweizer E, Galasko D. PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease. Alzheimer Dis Assoc Disord. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Frank G, Hennig-Fast K, Klünemann HH, Schmitz G, Greenlee MW. Differential Impact of ApoE e4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Picard C, Pasquier F, Martinaud O, Hannequin D, Godefroy O. Early Onset Dementia: Characteristics in a Large Cohort From Academic Memory Clinics. Alzheimer Dis Assoc Disord. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Sandoval KE, Farr SA, Banks WA, Niehoff ML, Morley JE, Crider AM, Witt KA. Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice. Eur J Pharmacol. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Quigley H, Colloby SJ, O'Brien JT. PET imaging of brain amyloid in dementia: a review. Int J Geriatr Psychiatry. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease. Int J Geriatr Psychiatry. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics. J Cell Physiol. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Neumann PJ, Cohen JT, Hammitt JK, Concannon TW, Auerbach HR, Fang C, Kent DM. Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Econ. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Venneri A, McGeown WJ, Biundo R, Mion M, Nichelli P, Shanks MF. The Neuroanatomical Substrate of Lexical-Semantic Decline in MCI APOE e4 Carriers and Noncarriers. Alzheimer Dis Assoc Disord. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Ohanna I, Golander H, Barak Y. Does late onset depression predispose to dementia? A retrospective, case-controlled study. Compr Psychiatry. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Caviness JN, Lue L, Adler CH, Walker DG. Parkinson's Disease Dementia and Potential Therapeutic Strategies. CNS Neurosci Ther. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Mishra M, Heese K. P60TRP interferes with the GPCR/secretase pathway to mediate neuronal survival and synaptogenesis. J Cell Mol Med. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Wu X, Lu Y, Dong Y, Zhang G, Zhang Y, Xu Z, Culley DJ, Crosby G, Marcantonio ER, Tanzi RE, Xie Z. The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-a, IL-6, and IL-1ß Neurobiol Aging. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Butterfield DA. Atorvastatin and Aß(1-40): Not as Simple as Cholesterol Reduction in Brain and Relevance to Alzheimer Disease. Exp Neurol. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
McNaughton D, Knight W, Guerreiro R, Ryan N, Lowe J, Poulter M, Nicholl DJ, Hardy J, Revesz T, Lowe J, Rossor M, Collinge J, Mead S. Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobiol Aging. 2010 Dec 28; Alzheimer’s Disease Vaccine 2010
Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22687-92. Alzheimer’s Disease Vaccine 2010
No comments:
Post a Comment